Mucopolysaccharidosis type 6 (MPS6) or Maroteaux Lamy syndrome is a rare autosomal recessive disorder characterized by the accumulation of mucopolysaccharides in connective tissues as a result of the reduced or absent activity of the lysosomal enzyme arylsulfatase B (ASB). This is a progressive disorder that affects numerous organs and tissues.
Presentation
MPS6 can be considered as a spectrum of the disease since the clinical picture can range from mild to severe. Patients with the rapidly progressive form develop symptoms between ages 2 and 3 years. This is typically characterized by limitations in joint motion during infancy, walking disabilities in childhood as well as delayed puberty, cervical spine compression, respiratory failure, and heart failure (second or third decade). The slowly progressive variant occurs at a later onset with a diagnosis often during the second or third decade although they may experience symptoms sooner.
Numerous organs systems are involved in MPS6:
Musculoskeletal
Patients very commonly exhibit a disproportionately short stature. Major skeletal abnormalities include hypoplastic bones, hip dysplasia, pectus carinatum, genu valgum, and kyphoscoliosis. Major sequelae include spinal cord compression, degenerative joint disease [9] [10], contractures, and arthritis. The affected individuals often suffer from pain, gait difficulties, and restriction of joint movement.
Face
In severe cases, patients display prominent facial characteristics. Examples include low and flat nasal bridge, frontal bossing, gingival hypertrophy, macroglossia, and hirsutism [9] [10].
Eyes and ears
Patients may have corneal opacification which causes glaucoma and papilledema [9] [10]. Hearing loss is common and can occur due to conductive or sensorineural etiologies.
Neurologic
Carpal tunnel syndrome is a frequent complication in individuals with MPS6. Furthermore, hydrocephalus is a more severe neurologic manifestation that occurs in some patients.
Gastrointestinal
Common findings on physical exam are hepatosplenomegaly and umbilical and inguinal hernias. The latter two develop as a result of weakened abdominal muscles.
Cardiac
Patients frequently have aortic, mitral, and tricuspid valvular disease. Also, structural pathologies such as cardiomyopathy and endocardial fibroelastosis are notable defects. As a result of cardiac involvement, patients exhibit failure to thrive and experience difficulty with feeding.
Pulmonary
Storage of mucopolysaccharides causes swelling of tissues, which leads to obstruction of the airways. Patients are typically susceptible to developing obstructive and restrictive lung disease which are accompanied by complications such as recurrent pneumonia and obstructive sleep apnea (OSA).
Cognitive
Intelligence is normal in these patients.
Immune System
- Splenomegaly
Immune System Splenomegaly Macrocephaly Enlarged tongue Prominent forehead Possible coarse texture of hair Hepatomegaly and splenomegaly are often present in patients with MPS VI. Umbilical and inguinal hernias are common. [symptoma.com]
Patient’s also often have enlargement of the spleen – a condition called “splenomegaly”. It is not uncommon for patients to have various types of hernias. [virtualmedstudent.com]
Macrocephaly Enlarged tongue Prominent forehead Possible coarse texture of hair Hepatomegaly and splenomegaly are often present in patients with MPS VI. Umbilical and inguinal hernias are common. [emedicine.medscape.com]
[…] lips, and enlarged mouth and tongue), short stature with disproportionately short trunk (dwarfism), dysplasia (abnormal bone size and/or shape) and other skeletal irregularities, thickened skin, enlarged organs such as liver (hepatomegaly) or spleen (splenomegaly [en.wikipedia.org]
Entire Body System
- Short Stature
The characteristic skeletal dysplasia includes short stature, dysostosis multiplex and degenerative joint disease. [malacards.org]
[virtualmedstudent.com] Entire body system Short Stature The characteristic skeletal dysplasia includes short stature, dysostosis multiplex and degenerative joint disease. [symptoma.com]
stature, hepatosplenomegaly, dysostosis multiplex, stiff joints, corneal clouding, cardiac abnormalities, and facial dysmorphism, with intelligence usually normal. [colombiamedica.univalle.edu.co]
- Pain
A dictionary of medical eponyms Related people Maurice Emile Joseph Lamy Pierre Maroteaux A familial type of bone dysplasia marked by short-trunk dwarfism, back pain, pain in the hips, and limitation of joint movement. [whonamedit.com]
Nausea, vomiting, elevated blood pressure, chest pain, abdominal pain, malaise, and joint pain were also reported. No patients discontinued Naglazyme treatment because of reactions. [biomarin.com]
[medical-dictionary.thefreedictionary.com] Pain An experiment was then carried out to see whether an injection of the missing enzyme into the hips would help the range of motion and pain. [symptoma.com]
She developed pain in the hips and fatigue. [pediatrics.aappublications.org]
The most common signs and symptoms in our series were bone abnormalities and hip pain as initial manifestations and cardiac changes detected after follow-up studies. [mayoclinic.pure.elsevier.com]
- Inguinal Hernia
Umbilical and inguinal hernias are common. [symptoma.com]
hernia, umbilical hernia, multiple dysostosis, hepatosplenomegaly and difficulty in breathing; surgical history: right inguinal herniorrhaphy, umbilical herniorrhaphy, changes compatible with mucopolysaccharidosis (MPS) type VI. [revistamedicina.net]
Other symptoms may include carpal tunnel syndrome, curvature of the spine, a frequent runny nose, inguinal hernias and hearing loss. Incidence Maroteaux-Lamy syndrome affects one in 200,000 people. [bmt.umn.edu]
Often these individuals also develop abnormalities of heart valves, hepatosplenomegaly and umbilical hernia or inguinal hernia. [ivami.com]
Early signs of the disease include umbilical and inguinal hernias, followed by abnormal structural development. Facial signs include enlarged tongue, prominent eyes, a flat nasal bridge, as well as macrocephaly. [eyewiki.aao.org]
- Difficulty Walking
[symptoma.com] Difficulty Walking Affected individuals may develop pain, especially of the joints and hip, spinal cord compression, an abnormal manner of walking (gait), or difficulty walking. [symptoma.com]
The main symptoms include: fatigue difficulty walking vision problems, such as blurred vision problems controlling the bladder numbness or tingling in different parts of the body muscle stiffness and spasms problems with balance and co-ordination problems [nhs.uk]
Affected individuals may develop pain, especially of the joints and hip, spinal cord compression, an abnormal manner of walking (gait), or difficulty walking. Affected joints may have a limited range of motion making daily tasks difficult. [rarediseases.org]
- Recurrent Otitis Media
We found ear, nose and throat manifestations in all types of MPS; in particular, recurrent otitis media was present in 30% of cases, hearing loss in 75% (mixed in 43.33%, conductive in 43.33%, sensorineural in 13.33%), adenotonsillar hypertrophy in 75% [ncbi.nlm.nih.gov]
otitis media Impaired hearing Recurrent sinopulmonary infections Upper airway obstruction Sleep apnea Reduced pulmonary function Cardiac abnormalities and valvular disease Hepatosplenomegaly Umbilical and inguinal hernias Reduced joint range of motion [biomarin.com]
[rarediseases.org] Recurrent Otitis Media We found ear, nose and throat manifestations in all types of MPS; in particular, recurrent otitis media was present in 30% of cases, hearing loss in 75% (mixed in 43.33%, conductive in 43.33%, sensorineural in [symptoma.com]
Recurrent respiratory infections were noted in 11 of the 27 patients (41%) and recurrent otitis media was seen in 19 (70%), all with documented conductive hearing loss and requiring pressure-equalizing tubes. [jamanetwork.com]
otitis media, and premature death [ 1, 2, 3, 4 ]. [ojrd.biomedcentral.com]
Gastrointestinal
- Failure to Thrive
[…] to Thrive As a result of cardiac involvement, patients exhibit failure to thrive and experience difficulty with feeding. [symptoma.com]
Affiliated tissues include heart, liver and brain, and related phenotypes are failure to thrive and coarse facial features Disease Ontology : 12 A mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme N-acetylgalactosamine 4-sulfatase [malacards.org]
Affected children may also exhibit failure to thrive and difficulty feeding. High blood pressure (hypertension) may also occur. [rarediseases.org]
Jaw & Teeth
- Macroglossia
[rarediseases.org] Jaw & Teeth Macroglossia ., ,, ,, Source MeSH Alveolar Process Child Consanguinity Dentigerous Cyst Gingival Hyperplasia Humans Macroglossia Male Mouth Abnormalities Mucopolysaccharidosis VI Open Bite Palate, Hard Pedigree Tooth Abnormalities [symptoma.com]
Links Publisher Full Text Authors +Show Affiliations, Faculty of Dentistry, Department of Pedondontics, Ege University, Bornova, Izmir, Turkey., ,, ,, Source MeSH Alveolar Process Child Consanguinity Dentigerous Cyst Gingival Hyperplasia Humans Macroglossia [unboundmedicine.com]
They have coarse facial and somatic features, umbilical and scrotal hernia, macroglossia, visceromegaly, disostosis multiplex and joint involvement. In most forms corneal cloudiness is seen. These symptoms usually appear during early infancy. [bhj.org.in]
The features of MPS VI include macrocephaly, hydrocephalus and macroglossia. Often these individuals also develop abnormalities of heart valves, hepatosplenomegaly and umbilical hernia or inguinal hernia. [ivami.com]
The features of MPS VI include a large head (macrocephaly), a buildup of fluid in the brain (hydrocephalus), distinctive-looking facial features that are described as "coarse," and a large tongue (macroglossia). [malacards.org]
- Gingival Hypertrophy
[rarediseases.org] Gingival Hypertrophy Examples include low and flat nasal bridge, frontal bossing, gingival hypertrophy, macroglossia, and hirsutism. Eyes and ears Patients may have corneal opacification which causes glaucoma and papilledema. [symptoma.com]
This syndrome resembles Hurler syndrome with typical facial changes including frontal bossing, a depressed nasal bridge, open mouth associated with enlarged tongue, gingival hypertrophy, delayed dental eruption, and hypertrichosis. [22] A large head, [emedicine.medscape.com]
Such characteristics include chubby faces, thickened lips due to the overgrowth of the gums (gingival hypertrophy), an unusually prominent forehead (frontal bossing), and a broad, flattened bridge of the nose. [rarediseases.org]
Cardiovascular
- Heart Failure
Because of the cardiac involvement, most patients with the severe forms of the disease will die of heart failure by the second or third decade. return to Inborn Errors page return to Glycosaminoglycans and Proteoglycans page Return to The Medical Biochemistry [themedicalbiochemistrypage.org]
[rarediseases.org] Cardiovascular Heart Failure Narrowing of the heart valves can progressively make it more difficult for the heart to pump blood and can eventually result in heart failure. [symptoma.com]
In severe cases of Maroteaux-Lamy syndrome, symptoms include mobility issues (problems walking), total absence of or delay with puberty, and heart failure in early 20s-30s. [patientworthy.com]
Acquired heart block has many possible causes, including heart attack (the most common cause), heart disease, an enlarged heart (cardiomyopathy), heart failure and rheumatic fever. [my.clevelandclinic.org]
Liver, Gall & Pancreas
- Hepatosplenomegaly
This disorder is characterized by normal cognition, coarse faces and dysostosis multiplex, hepatosplenomegaly, and cardiac valve disease. [malacards.org]
Clinical findings Abnormal growth, short stature, stiff joints, skeletal malformations, corneal clouding, hepatosplenomegaly and cardiac defects. [medical-dictionary.thefreedictionary.com]
[termedia.pl] Liver, Gall & Pancreas Hepatosplenomegaly Clinical findings Abnormal growth, short stature, stiff joints, skeletal malformations, corneal clouding, hepatosplenomegaly and cardiac defects. [symptoma.com]
Hepatosplenomegaly is always present in Maroteaux-Lamy patients after the age of 6. [themedicalbiochemistrypage.org]
Rodriguez Full Text: PDF(EN) PDF(ES) HTML Abstract Mucopolysaccharidosis type VI or Maroteaux Lamy syndrome is an autosomal recessive lysosomal storage disorder resulting from a deficiency of arylsulfatase B, the clinical features include short stature, hepatosplenomegaly [colombiamedica.univalle.edu.co]
- Hepatomegaly
We report a case of Maroteaux-Lamy syndrome in a child aged 9 years whose diagnosis was suspected clinically by the combination of a dysmorphic syndrome, prominent ophthalmological signs, hepatomegaly and normal intelligence. [scopemed.org]
Sistemik muayenede korneal bulutlanma (11 olgu) işitme kaybı (5 olgu), hepatomegali (4 olgu), adenoid hipertrofi (opere edilmiş 4 olgu), kardiyak tutulum (9 olgu), tüm hastalarda kemik incelemede disostozis multipleks bulguları saptandı. [egetipdergisi.com.tr]
[emedicine.medscape.com] Abnormal enlargement of the liver ( hepatomegaly ) is common in individuals with Maroteaux-Lamy syndrome. Less often, the spleen may also be enlarged (splenomegaly). [symptoma.com]
Hepatomegaly, corneal clouding, claw-hand deformities, cardiac valve involvement, decreased pulmonary function, and sleep apnea become evident as the child ages. Respiratory infections are common. [egl-eurofins.com]
Skin
- Hirsutism
[rarediseases.org] Skin Hirsutism Patients with MPS III are mentally retarded with severe hirsutism and synophrys. All mucopolysaccharidoses are inherited as autosomal recessive except for the Hunter syndrome (MPS II) which is an x linked disease. [symptoma.com]
Patients with MPS III are mentally retarded with severe hirsutism and synophrys. All mucopolysaccharidoses are inherited as autosomal recessive except for the Hunter syndrome (MPS II) which is an x linked disease. CASE REPORT Mrs. [bhj.org.in]
Hirsutism is common. Children become inattentive and deteriorate rapidly, losing the power of speech. Mild hepatosplenomegaly is common. Osteoporosis and osteomalacia are possible skeletal defects. [emedicine.medscape.com]
- Hypertrichosis
Hypertrichosis is common. Grouped skin-colored papules were described in 1 child with Hurler-Scheie syndrome. [emedicine.medscape.com]
[…] malformation), macrocephaly, hepatosplenomegaly, protruding abdomen, umbilical and/or inguinal hernia, coarse facial features (Fig 1) including frontal bossing, a depressed nasal bridge, enlarged tongue, gingival hypertrophy, delayed dental eruption, and hypertrichosis [ojrd.biomedcentral.com]
Eyes
- Corneal Opacity
A large head, short neck, corneal opacity, open mouth associated with an enlarged tongue, enlargement of skull, and a long antero-posterior dimension are the main characteristic features. [unboundmedicine.com]
On the other hand, these deposits may be present in most patients, but given the high prevalence of corneal opacity in MPS VI, these deposits become difficult to see and may go unnoticed. [eyewiki.aao.org]
Corneal opacities were found in 3 patients [16.7%] and progressive increase in intraocular pressure in 1 patient [5.6%], while fundus examination showed early optic atrophy in 1 patient [5.6%] and bilateral papilloedema in 2 patients [11.1%] Citation [apps.who.int]
Hearing loss [2], corneal opacities [54, 55]. Hepatosplenomegaly, umbilical and inguinal hernias [39, 40]. [hindawi.com]
- Visual Impairment
Although mental development proceeds normally in Maroteaux-Lamy patients, the progression of physical and visual impairments ultimately impedes psychomotor abilities. [themedicalbiochemistrypage.org]
The main cause of visual impairment in these patients is, as noted above, the deposition of glycosaminoglycans at the cornea and subsequent hypo-transparency[7]. [eyewiki.aao.org]
It is characterized by normal intelligence and stature; however, affected individuals do experience joint involvement, visual impairment, and obstructive airway disease. [neurology.testcatalog.org]
Involvement of other organ systems can lead to significant morbidity, including respiratory compromise, obstructive sleep apnea, valvular heart disease, hearing impairment, visual impairment from corneal clouding, dental abnormalities, and hepatomegaly [ncbi.nlm.nih.gov]
Ears
- Hearing Impairment
Main symptoms and co-morbidities of MPS IV include: Recurrent upper respiratory tract infections Sleep apnoea Pulmonary hypertension Osteoporosis Inguinal hernia Hepatomegaly Dental caries Vision impairment Hearing impairment and loss Disturbances in [giikorea.co.kr]
Associated with these, there is also delayed puberty, hepatoesplenomegaly, umbilical and/or inguinal hernia, stunted stature growth with percentiles lower than 50 since 2 years of age.1 The otorhinolaryngological engagement implies hearing impairment, [journals.sagepub.com]
Intelligence is usually normal, but visual and hearing impairments are present. Compression of the spinal cord with successive neurologic complications can appear because of hypoplasia of the cervical vertebrae. [emedicine.medscape.com]
- Hearing Problem
In rare cases, hearing loss may be due to a combination of both problems (mixed hearing loss). Abnormalities of the heart are common in children with Maroteaux-Lamy syndrome. [rarediseases.org]
Moreover, seven out of nine patients presented with corneal clouding at enrollment in the study, but this did not affect their visual acuity [55], while hearing problems were only registered in one patient. [mdpi.com]
Musculoskeletal
- Joint Stiffness
Indications Corneal clouding, joint stiffness, dyostosis multiplex, short stature, coarse features, normal intellect Methodology Enzymatic reaction detected by spectrophotometric assay. [egl-eurofins.com]
MPS-VI (Maroteaux-Lamy Syndrome) is an autosomal recessive syndrome due to deficiency of enzyme Aryl- Sulfatase -B, and is characterized by characteristic facies, normal intelligence, Dysostosis multiplex, organomegaly, joint stiffness, corneal clouding [link.springer.com]
The patient represents relatively attenuated MPS VI with osteo-articular and cardiac changes (Table I, II, Figure 1, 2). keywords: mucopolysaccharidosis type VI, Maroteaux-Lamy syndrome, joint stiffness, progressive limitation of joint mobility, dysostosis [termedia.pl]
Orthopedic-Bone Changes Short neck, joints stiffness [47], odontoid instability [48], hypo plastic mandible, thoracic cage restriction for kyphoscoliosis [24]. [hindawi.com]
Restricted breathing, joint stiffness, and heart disease are also common. Children with the more, severe form of Morquio syndrome may not live beyond their twenties or thirties. [en.wikipedia.org]
- Macrocephaly
[symptoma.com] Macrocephaly Macrocephaly and sternal abnormalities can be present at birth, and inguinal/umbilical hernias are common. [symptoma.com]
Macrocephaly and sternal abnormalities can be present at birth, and inguinal/umbilical hernias are common. Restriction of joint movement develops sometime in the first few years of life, and a typical crouched posture is assumed. [egl-eurofins.com]
May include: Macrocephaly, Hydrocephalus, Coarse facial features, Heart valve disease, Enlarged liver and spleen, Umbilical hernia[2] Usual onset Patients are affected at birth; symptoms usually appear during early childhood Duration Lifelong Causes Mutations [en.wikipedia.org]
The features of MPS VI include macrocephaly, hydrocephalus and macroglossia. Often these individuals also develop abnormalities of heart valves, hepatosplenomegaly and umbilical hernia or inguinal hernia. [ivami.com]
The phenotype varies significantly from mild to severe presentations and may include macrocephaly, short stature, dysostosis multiplex, hepatomegaly, coarse facies, and impairment of cognitive function. [neurology.testcatalog.org]
- Arthritis
Major sequelae include spinal cord compression, degenerative joint disease, contractures, and arthritis. The affected individuals often suffer from pain, gait difficulties, and restriction of joint movement. [symptoma.com]
Additionally, it is widely accepted that infection with this organism can result in a variety of extrapulmonary sequelae including septic arthritis, hemolytic anemia, dermatological, renal, central nervous system and cardiac complications. [uniprot.org]
Moderately advanced secondary degenerative arthritis is present at the superior hip joint. Focal articular surface irregularity with slight collapse superiorly could be due to superimposed avascular necrosis. [pediatrics.aappublications.org]
- Genu Valgum
Ma·ro·teaux-·La·my syn·drome ( mah-rō-tō' lah'mē ), [MIM*253200] an error of mucopolysaccharide metabolism characterized by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly [medical-dictionary.thefreedictionary.com]
genu valgum, usually hepatosplenomegaly [medical-dictionary.thefreedictionary.com] Major skeletal abnormalities include hypoplastic bones, hip dysplasia, pectus carinatum, genu valgum, and kyphoscoliosis. [symptoma.com]
Other signs and symptoms include thickened facial features, coarse hair, genu valgum, short neck, frequent ear and upper respiratory tract infections, and hearing loss. Hirsutism is common. [emedicine.medscape.com]
- Joint Deformity
Likewise, the disease causes various skeletal abnormalities which are most noticeable with age, including short stature, joint deformities that affect mobility, dysostosis multiplex, carpal tunnel syndrome and spinal stenosis in the neck that can compress [ivami.com]
MPS VI causes various skeletal abnormalities, including short stature and joint deformities (contractures) that affect mobility. [malacards.org]
[rarediseases.org] Joint Deformity Likewise, the disease causes various skeletal abnormalities which are most noticeable with age, including short stature, joint deformities that affect mobility, dysostosis multiplex, carpal tunnel syndrome and spinal [symptoma.com]
Other skeletal features include short stature, joint deformities (contractures) that affect mobility, and dysostosis multiplex, which refers to multiple skeletal abnormalities seen on x-ray. [medlineplus.gov]
Face, Head & Neck
- Frontal Bossing
[symptoma.com] Face, Head & Neck Frontal Bossing Examples include low and flat nasal bridge, frontal bossing, gingival hypertrophy, macroglossia, and hirsutism. [symptoma.com]
Radiology of skull, face, chest, long bones, and spine showed short stubby small bones, frontal bossing, thick ribs, thickened metaphyses of long bones, spinal thoracolumbar kyphosis highly suggestive of MPS (type IV). [jcor.in]
This syndrome resembles Hurler syndrome with typical facial changes including frontal bossing, a depressed nasal bridge, open mouth associated with enlarged tongue, gingival hypertrophy, delayed dental eruption, and hypertrichosis. [22] A large head, [emedicine.medscape.com]
- Coarse Face
This disorder is characterized by normal cognition, coarse faces and dysostosis multiplex, hepatosplenomegaly, and cardiac valve disease. [malacards.org]
Patients with the rapid progressing form of the disease represent skeletal abnormalities, joint stiffness and deformities, short stature with reduced growth rate, cardiovascular symptoms, coarse face and recurrent upper airway obstructions and infections [degruyter.com]
Neurologic
- Communicating Hydrocephalus
Clinical confirmation of papilledema and communicating hydrocephalus has been obtained in a child with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, Type VI). [jhu.pure.elsevier.com]
Although intellectual deficit is generally absent in MPS 6, central nervous system findings may include cervical cord compression caused by cervical spinal instability, meningeal thickening and/or bony stenosis, communicating hydrocephalus, optic nerve [orpha.net]
- Papilledema
Clinical confirmation of papilledema and communicating hydrocephalus has been obtained in a child with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, Type VI). [jhu.pure.elsevier.com]
[rarediseases.org] Neurologic Papilledema Clinical confirmation of papilledema and communicating hydrocephalus has been obtained in a child with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, Type VI). [symptoma.com]
Ocular manifestations include corneal clouding, ptosis, acute and chronic angle-closure and open-angle glaucoma, optic nerve atrophy, and papilledema[3]. [eyewiki.aao.org]
Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme®) therapy. Int Ophthalmol. 2008; 29(4): 267-269. 15. Harmatz P. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis VI: clinical facts and figures. Turk J. [revistamedicina.net]
- Abnormal Gait
MPS IVA patients with abnormal gait, total (000s) Table 16. MPS IVA patients with genu valgum, total (000s) Table 17. MPS IVA patients with eye problems, total (000s) Table 18. [giikorea.co.kr]
Workup
Patients suspected to have this disease should be assessed thoroughly through a full personal and family history, a complete physical exam, and the appropriate key tests.
Laboratory testing
The initial diagnostic study is the qualitative and quantitative analysis of urinary GAGs, which establishes the general diagnosis of MPS6. While quantitative assessment yields the measurement of the amount of GAGs, qualitative methods identify the specific GAG that is increased. To obtain the latter, techniques such as thin-layer chromatography (TLC) and/or electrophoresis (ELP) are utilized [11]. It is important that both qualitative and quantitative methods should be performed to avoid false conclusions.
Further studies include the evaluation of the enzymatic activity of ASB using dried blood spots, cultured fibroblasts or leukocytes, of which last two are the gold standard samples [11]. With regards to the level of enzymatic activity, it is not predictive of the clinical course.
If possible the ARSB gene can be assessed for detection of the mutation(s) [11].
Other
Imaging tools should be performed to identify skeletal defects. Furthermore, echocardiography is used to evaluate valvular abnormalities, wall thickness, and other findings. Also, magnetic resonance imaging (MRI) of the brain and spine is important to determine the presence of spinal cord compression, hydrocephalus, and other findings.
Further testing depends on the clinical picture. Hence, additional tests include:
- Audiogram
- Ophthalmology assessment
- Pulmonary function tests
Treatment
Management of patients with MPS6 is best provided by a team of pediatricians, orthopedic surgeons, cardiologists, pulmonologists, dentists, ophthalmologists, audiologists, geneticists, and other specialists as needed.
The two standard treatments currently used are enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT).
ERT
One orphan drug, galsulfase, has been approved by the Food and Drug Association (FDA) since 2005. As a recombinant form of arylsulphatase B, galsulfase provides the patient with an exogenous supply of the deficient enzyme. According to a long-term follow-up study, patients receiving weekly infusions demonstrated a significant decline in urinary GAGs [12]. It is also associated with improvement in walking and stair climbing capacity, and in the range of motion of joints as well [13]. Side effects were deemed acceptable [12].
HSCT
The goal of stem cell transplantation is to endogenously supply the enzyme through the production of a new stem cell population. This treatment is associated with high morbidity and mortality as one study reported a one-year survival rate of 67% [14].
Surgical intervention
Orthopedic surgical procedures may be needed for patients with spinal cord compression, atlantoaxial imbalance, hip dysplasia, carpal tunnel syndrome, and other defects. Additionally, neurosurgery is required for ventriculoperitoneal shunt placement in patients with hydrocephalus. Very importantly, cardiac surgery may be indicated in cases with valvular abnormalities.
Other
Physical rehabilitation including physical and occupational therapy should be instituted early. Additionally, psychosocial support should be provided to the children and their parents. There are resources such as support groups and community programs to assist the families.
Prognosis
The prognosis is influenced by numerous factors, which are the age of onset, the rate of progression, and the age at which therapy was initiated. Additionally, the quality of care received by the patient plays a role in the overall outcome. With regards to biochemical manifestations, a urinary GAG level greater than 100 μg/mg creatinine is indicative of a poor prognosis.
Early recognition and treatment is very important in improving the prognosis since both forms, rapid and slowly progressive, can cause irreversible damage. Therefore, treatment should not be delayed.
In a long-term study, ERT prolonged survival. It was also observed to improve growth, endurance, and pulmonary function [8]. However, ERT did not impact variables measuring the quality of life such as pain or disability [8].
Etiology
The etiology of this autosomal recessive disorder is a mutation in the ARSB gene, which codes for the lysosomal enzyme known as ASB. The latter plays a key role in the breakdown of GAGs such as dermatan sulfate and chondroitin sulfate. Hence, a deficiency in this lysosomal enzyme leads to an accumulation of dermatan sulfate in the various organs and tissues of the body.
Epidemiology
The estimated incidence of MPS6 ranges from 1 in 248,000 to 1 in 300,000 live births [3]. With regards to patient demographics, there is no gender preference.
One community observed to have a higher frequency is the city of Monte Santo located in the northeastern region of Brazil. The prevalence in this population is greater than that noted in the literature [4]. Furthermore, there were numerous patients diagnosed with Maroteaux Lamy syndrome in Colombia [5].
Pathophysiology
MPS6 develops secondary to mutations on chromosome 5 [5], of which missense mutations account for most of the genetic defects [6].
The disease manifests when there is a profound deficiency in enzymatic activity [7], in which the absent or severely low levels of ASB enzyme are incapable of performing a complete degradation of GAGs. The latter are major components of connective tissues and are constituted of unbranched chains of polysaccharides composed of repetitive disaccharides.
As a result, dermatan sulfate, a type of GAG, builds up in sites that are prominently composed of connective tissue such as the skeleton, joints, heart valves, vessels, ears, eyes, and/or teeth. This disease is characterized by progressive damage to these sites.
There is often multisystem involvement of the skeletal, cardiovascular, respiratory, gastrointestinal, and central nervous systems. Hence, the clinical picture may include bone dysplasia, short stature, joint stiffness, coarse facies, organomegaly, corneal clouding, cardiac and pulmonary abnormalities, etc. Patients commonly have a decreased life expectancy and exhibit decreased exercise capacity, reduced endurance, and a restricted range of motion in the joints [3].
Prevention
While there are no preventative measures, parents with known personal and/or family genetic defects can be offered biochemical prenatal testing. Samples can be obtained from amniocytes [15].
Additionally, patients and family members should seek genetic counseling to receive education about what the disease entails, its mode of inheritance, the prognosis, and other relevant information.
Summary
Mucopolysaccharidosis (MPS) type 6 is also referred to as Maroteaux Lamy syndrome. The MPSs encompass a group of inherited lysosomal disorders that result from mutations in arylsulfatase B (ARSB) gene. The genetic defects lead to a deficiency in the activity of the lysosomal enzyme, ASB, which is necessary for the catabolism of mucopolysaccharides or glycosaminoglycans (GAGs). This culminates in the buildup of GAGS in various organs and tissues.
The clinical manifestations reflect the accumulation of GAGs in the involved connective tissues such as the skeleton, heart valves, eyes, ears, etc. The symptomology varies and includes skeletal dysplasia, dwarfism, joint restriction, abnormal facies, and other features as well [1] [2]. There are two variants which are characterized by the rate of disease progression and age of onset: rapidly progressive and slowly progressive.
The clinical assessment includes the personal and family history, a full physical examination, and appropriate testing. The diagnostic tools consist of the quantitative and qualitative analysis of urinary GAGs followed by the measurement of the enzyme's activity. Additional studies such as a skeletal survey and echocardiogram should be performed in accordance with the clinical picture.
The patients should receive comprehensive care by a multidisciplinary team of specialists. The medical management of Maroteaux Lamy syndrome consists of enzyme replacement therapy (ERT) or hematopoietic stem cell transplantation (HSCT). ERT is associated with significant improvement in multiple aspects of the disease including survival.
Prompt diagnosis and early treatment with ERT can profoundly impact the outcome. Sometimes Maroteaux Lamy syndrome can be detected prenatally. Genetic counseling is available to affected individuals and their family members.
Patient Information
What is mucopolysaccharidosis (MPS) type 6?
The mucopolysaccharidoses (MPS) is a group of inherited diseases that develop due to a deficiency of a specific type of lysosomal enzyme called arylsulfatase B. Normally, this enzyme breaks down complex carbohydrates called mucopolysaccharides. Therefore, if this enzyme is absent, mucopolysaccharides will accumulate in various organs and tissues such as the skeleton, joints, ears, eyes, skin, heart, liver, and/or teeth.
What causes this disease?
This disease develops as a result of mutations in the ARSB gene, which provides instructions to produce the arylsulfatase B enzyme. Mucopolysaccharidosis type 6 is inherited in an autosomal recessive pattern. In other words, the affected child received two bad copies of the gene, one from each parent.
What are the signs and symptoms?
Some patients will have a rapidly progressive form, in which they develop symptoms between ages 2 and 3 years. Others will have the slowly progressive type which develops at a later onset with a diagnosis often during the second or third decade although they may experience symptoms sooner. Many organs are affected. Signs and symptoms include:
- Musculoskeletal: Short stature, underdeveloped bones, hip deformities, and chest deformities
- Neurology: Spinal cord compression, carpal tunnel syndrome
- Joint disease: Arthritis, contractures, restricted movement of joints
- Facial features: Flat nasal bridge, prominent forehead, overgrowth of the gums, large tongue, and hair growth on face
- Eyes: Clouding of the corneas
- Ears: Hearing loss, ear infections
- Abdomen: Enlargement of the liver and spleen
- Heart: Diseases of the heart valves, high blood pressure, weakening of the heart wall
- Head: Hydrocephalus (accumulation of a large amount of cerebrospinal fluid in the skull)
- Pulmonary: Recurrent pneumonia and obstructive sleep apnea
- Other: Difficult to feed and thrive, delayed puberty, difficulty walking
How is it diagnosed?
In children suspected to have mucopolysaccharidosis (MPS) type 6, the clinician will obtain a thorough history of the patient and the family, perform a physical exam, and order the appropriate tests such as:
- Patient's urine will be assessed for the levels of mucopolysaccharides
- Blood and skin cells can be evaluated to determine the activity of the enzyme
- Genetic testing can be done to detect the mutation
Other tests should look for clinical manifestations:
- X-rays of the skeleton
- Echocardiography
- MRI of the brain and spine
- Audiogram
- Ophthalmology assessment
- Pulmonary function tests
How is it treated?
The treatment is best provided by a multidisciplinary team consisting of pediatricians, orthopedic surgeons, cardiologists, pulmonologists, dentists, ophthalmologists, audiologists, geneticists, and other specialists as needed.
The two standard treatments currently used are enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT). With ERT, patients are treated with an intravenous medication called Naglazyme (galsulfase), which is a recombinant form of the enzyme. Therefore, the patient receives the missing enzyme through the treatment.
Stem cell transplantation is associated with severe side effects and high risk of death.
What is the prognosis?
It is important to diagnose and treat the disease as soon as possible. Treatment with enzyme replacement therapy has shown to improve survival, walking, endurance, and joint movement.
Can this be prevented?
Since this disease is inherited, it cannot be prevented. Patients and affected family members are encouraged to receive genetic counseling to learn about the disease, what it entails, how it is inherited, and other important information.
The family should be provided with numerous community and state resources.
References
- Kantaputra PN, Kayserili H, Güven Y, et al. Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI. Journal of Inherited Metabolic Disorders. 2014; 37(2):263-8.
- Borlot F, Arantes PR, Quaio CR, et al. New insights in mucopolysaccharidosis type VI: neurological perspective. Brain Development. 2014; 36 (7):585-92.
- El Dib RP, Pastores GM. A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux–Lamy syndrome): focus on galsulfase. Biologics. 2009; 3:459–468.
- Costa-Motta FM, Acosta AX, Abé-Sandes K, et al. Genetic studies in a cluster of mucopolysaccharidosis type VI patients in Northeast Brazil. Molecular Genetics and Metabolism. 2011; 104(4):603–607.
- Litjens T, Baker EG, Beckmann KR, et al. Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase. Human Genetics. 1989; 82(1):67–68.
- Sandberg S, Deanching M, Hoganson G, et al. Pseudo-deficiency allele of N-acetylgalactosamine-4-sulfatase gene identified in a family with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Molecular Genetics and Metabolism. 2008; 93(2):34-34.
- Brooks DA, Gibson GJ, Karageorgos L, et al. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Molecular Genetics and Metabolism. 2005; 85(3):236–238.
- Giugliani R, Lampe C, Guffon N, et al. Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) — 10- year follow-up of patients who previously participated in an MPS VI survey study. American Journal of Medical Genetics Part A. 2014; 164(8):1953-1964.
- Koseoglu ST, Harmatz P, Turbeville S, et al. Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme) therapy. International Ophthalmology. 2009; 29(4):267–269.
- Gomes BD, Souza Gda S, Viana GM, et al. Visual dysfunction of Type I and VI mucopolysaccharidosis patients evaluated with visual evoked cortical potential. Case Reports in Ophthalmology. 2012; 3(1):104–112.
- Giugliani R, Brusius-Facchin A, Souza C, et al. Diagnosis and therapy options in mucopolysaccharidosis II (Hunter syndrome). Expert Opinion on Orphan Drugs. 2015; 3(2):10.
- Harmatz P, Giugliani R, Schwartz IV, et al. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Molecular Genetics and Metabolism. 2008; 94(4):469–475.
- Sohn YB, Park SW, Kim SH, et al. Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation. American Journal of Medical Genetics A. 2012; 158A(5):1158-63.
- Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Seminars in Hematology. 2010; 47(1):59-69.
- Wood T, Bodamer OA, Burin MG, et al. Expert recommendations for the laboratory diagnosis of MPS VI. Molecular Genetics and Metab. 2012; 106(1):73–82.